Cristina DeLeone is NP's Executive Assistant. I do not believe she is the company's PR lead (I really hope she isn't at least - but it might explain some past PRs...).

All this helps get Cytodyn's name out to the masses - it will lead many to speculate on the upside, many to investigate and discover the irrefutable science, any many others to make a bet on shorting the stock. This is the market at play. This isn't the first company on the verge of a major breakthrough to have a national media publication cast some doubt on it.

Until M/M data is released, it could be a wild ride. But this article changes nothing in terms of the underlying premise of course.